MedAlliance announces Completion of Enrolment in PRISTINE Clin... - 13 August 2021 08:00

NYON, Switzerland, Aug. 13, 2021/PRNewswire-AsiaNet/ -- MedAlliance has announced completion of patient enrolment in the PRISTINE clinical trial with SELUTION SLR(TM) 018 DEB (drug-eluting balloon) for the treatment of patients with Below-the-Knee (BTK) disease. SELUTION SLR is the first DEB to be ...

  Ascensia Presents First Ever Data At Australasian Diabetes Con... - 11 August 2021 09:00

SYDNEY Aug. 11, 2021 /PRNewswire-AsiaNet/ Ascensia Diabetes Care, a global diabetes company has today disclosed data at the virtual Australasian Diabetes Conference (ADC) 2021, which takes place August 11-13. The two posters presented for the first time data that analysed CONTOUR(R)DIABET...

  Novaliq Completes Enrollment of Second Phase 3 Study for CyclA... - 10 August 2021 22:00

HEIDELBERG, Germany and CAMBRIDGE, MA, Aug. 10, 2021 /PRNewswire-AsiaNet/ -- Novaliq, a biopharmaceutical company focusing on first- and best-in-class ocular therapeutics based on the unique EyeSol(R) water-free technology, today announced the second of two Phase 3 (ESSENCE-2) studies, evaluating the investigational drug C...

  Taiwan's medical device company challenges the limit of scienc... - 06 August 2021 19:18

TAIPEI, Aug. 9, 2021 /PRNewswire-AsiaNet/ -- As consumers around the world increase their awareness of using beauty and health products, collagen products have become the most popular item. Various manufacturers continue to innovate in accordance with consumer demand. According to Research a...

  Novavax Announces COVID-19 Vaccine Booster Data Demonstrating ... - 06 August 2021 06:47

GAITHERSBURG, Md., Aug. 6, 2021 /PRNewswire-AsiaNet/ -- - Single booster dose at 6 months of NVX-CoV2373 increased wild-type neutralizing antibodies more than 4-fold versus primary vaccination series - Six-fold increase in cross-reactive functional antibodies to Delta variant compared to primary va...

  Novavax and Serum Institute of India Announce Submission to Re... - 06 August 2021 06:33

GAITHERSBURG, Md., Aug. 6, 2021 /PRNewswire-AsiaNet/-- - Novavax and Serum Institute of India file regulatory submissions to the Drugs Controller General of India and to regulatory agencies in Indonesia and Philippines for Novavax' recombinant nanoparticle COVID-19 vaccine - Filing for World Health...

  KYOWA Pharmaceutical Industry Co. Ltd. Partners with Bora Phar... - 05 August 2021 17:28

TAIPEI, Aug. 5, 2021 /PRNewswire-AsiaNet/ -- KYOWA Pharmaceutical Industry Co. Ltd., a premier Japanese pharmaceutical company, has contracted with Bora Pharmaceutical Laboratories Inc. (Zhunan), a division of Bora Pharmaceuticals for the manufacturing of generic product for filing in Japan....

  Novavax and European Commission Finalize Advance Purchase Agre... - 04 August 2021 23:44

GAITHERSBURG, Md., Aug. 4, 2021 /PRNewswire-AsiaNet/ -- -- Agreement for 100 million doses with option for additional 100 million doses through 2023 -- Expected to be the first protein subunit COVID-19 vaccine available in the European Union Novavax, Inc. (Nasdaq: NVAX), a biotechnology company d...

  MitraClip implant at Apollo Hospitals saves 41-year-old farmer... - 04 August 2021 21:24

CHENNAI, India, August 04, 2021 /PRNewswire-AsiaNet/ -- “1 out of 5 patients may get off the heart transplant list if they have access to this therapy" - says Dr. Sai Satish Apollo Hospitals, Asia's foremost and most trusted healthcare group, today announced a successful MitraClip implant on...

  CartiHeal Announces Pivotal Study Results Demonstrate Agili-C(... - 03 August 2021 22:25

KFAR SABA, Israel, Aug. 3, 2021 /PRNewswire-AsiaNet/ -- According to a Two-Year Randomized and Controlled Multinational IDE Study CartiHeal Ltd, developer of Agili-C(TM), a proprietary implant for the treatment of cartilage lesions in arthritic and non-arthritic joints, which was granted Breakthroug...